Late Stage Investors & VC Firms in China

123 firms in this list, with a median first check of $1M. 6 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
NE New Alliance Capital LQ1 person	88🔒	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
PA Panacea Venture JH1 person	88🔒	Shanghai	CN	Series A–Late Stage	—	+ Add to CRM
SA Sangel Capital ML1 person	88🔒	Shenzhen	CN	Seed–Late Stage	—	+ Add to CRM
SH Shanghai STVC Group MZ1 person	88🔒	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
SH Sheares Healthcare Group TU1 person	88🔒	—	SG	Seed–Late Stage	—	+ Add to CRM
SH Sherpa Healthcare Partners DC1 person	88🔒	Grand Cayman	CN	Seed–Late Stage	—	+ Add to CRM
V V Ventures MS1 person	88🔒	Lewes	US	Seed–Late Stage	—	+ Add to CRM
WA Walden International	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
AD ADM Capital	88🔒	Wanchai	HK	Growth–Late Stage	—	+ Add to CRM
BO Boyu Capital	88🔒	Grand Cayman	HK	Growth–Late Stage	—	+ Add to CRM
CB CBC Group	88🔒	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
CD Cdh Venture Management Company Limited	88🔒	Hong Kong	CN	Seed–Late Stage	—	+ Add to CRM
CE Centurium Capital	88🔒	Beijing	CN	Growth–Late Stage	—	+ Add to CRM
CH China Merchants Capital	88🔒	Shenzhen	CN	Growth–Late Stage	—	+ Add to CRM
CI CICC	88🔒	Beijing	CN	Growth–Late Stage	—	+ Add to CRM
CP CPE	88🔒	Beijing	CN	Growth–Late Stage	—	+ Add to CRM
DC DCP Capital	88🔒	Beijing	CN	Growth–Late Stage	—	+ Add to CRM
EV Everbright Investments	88🔒	Hong Kong	HK	Growth–Late Stage	—	+ Add to CRM
FO FountainVest Partners	88🔒	Hong Kong	HK	Growth–Late Stage	—	+ Add to CRM
IN InnoVen Capital	88🔒	Beijing	CN	Series A–Late Stage	—	+ Add to CRM
JE Jebsen Capital	88🔒	Hong Kong	HK	Series A–Late Stage	—	+ Add to CRM
LI Lilly Asia Ventures	88🔒	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
MI Microsoft ScaleUp	88🔒	Beijing	CN	Pre-Seed–Late Stage	—	+ Add to CRM
NE Nexus Australia–China Startup Program	88🔒	Melbourne	AU	Series A–Late Stage	—	+ Add to CRM

Data sourced from public filings and firms' own websites — see our methodology.